Celltrion Healthcare Rises 7.1% Amid K-New Deal Index (Bio) Theme Uptrend

On the 28th, the K-New Deal Index (Bio) theme showed a strong performance, rising 3.86% compared to the previous day, while Celltrion Healthcare, a related stock attracting attention, surged 7.1% from the previous day. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

[Graph] K-New Deal Index (Bio) Theme Major Stocks Price Change Rates

According to the analysis by Thinkpool Robo Algorithm RASSI, Celltrion Healthcare's quant financial score is 41.53 points, ranking 5th within the K-New Deal Index (Bio) theme, with higher stability and profitability scores than the average of other related stocks. This indicates that, from a financial perspective, Celltrion Healthcare's ability to respond to internal and external economic environment changes and its efficient profit-generating capability are better compared to other stocks in the theme.

[Table] Top Financial Scores within the Theme

※ The quant financial score is the result of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.